Introduction
Bovine herpesvirus 1 (BoHV-1) and BoHV-5 are two closely related members of the subfamily Alphaherpesvirinae. The sequences of both viral genomes have been published (BoHV-1: AJ00480.1, BoHV-5: NC_005261.1). The approximately 70 genes are arranged in a colinear fashion, and the encoded proteins show 82% amino acid sequence identity on average (Delhon et al., 2003; Schwyzer and Ackermann, 1996) . Nevertheless, the viruses exhibit a different pathogenicity: BoHV-5 is strongly neuropathogenic in young calves (Meyer et al., 2001 ), rabbits (Meyer et al., 1996) and immunodeficient mice where infection leads to fatal encephalitis. Although BoHV-1 is also a neurotropic pathogen, it is usually unable to invade the central nervous system (CNS) and cause neurological disease to any significant degree (Muylkens et al., 2007) . The molecular basis for the different neuropathogenicity of the two viruses is known only in part (Del Medico Zajac et al., 2009a) . Glycoprotein E (gE) and the tegument protein US9 are thought to play a role in neurovirulence (AlMubarak and Chowdhury, 2004; Chowdhury et al., 2000; Chowdhury et al., 2002) .
During the lytic infection cycle, the genes of both viruses are expressed in three temporal phases termed immediate early (IE), early and late. Three major IE proteins, named BICP0, BICP4, and BICP22, regulate these phases by either transactivating or transrepressing specific virus genes. The IE proteins interact as multifunctional units with specific host cell proteins (Jones and Chowdhury, 2007; Saydam et al., 2004; Saydam et al., 2006) .
Both viruses establish latency in sensory neurons, where their genomes persist for the host's lifetime, awaiting reactivation into a new lytic cycle. During latency of BoHV-1 in trigeminal ganglia, only the latency related (LR) transcripts that overlap a large part of the BICP0 gene in the opposite direction, and the ORF-E transcripts, which are transcribed just downstream from BICP0 in the same direction, are detectable. LR and ORF-E gene products promote establishment and maintenance of latency; BICP0 promotes the reactivation 4 cycle (Jones and Chowdhury, 2007) . In BoHV-5, however, equivalents of LR and ORF-E have not been detected, nor can their features be recognized in the sequence. Counterparts of BICP0, named BICP0-1 and BICP0-5, do exist but are only moderately conserved (70% amino acid identity), which may contribute to the divergent phenotype. Towards clarification of this assumption and assisted by BAC technology, we generated recombinant BoHV-1, in which the BICP0-1 gene was replaced by genes encoding variants of BICP0-5. Here we show that BICP0-5 functionally complements BICP0-1.
Material and methods

Cell culture and virus
Madin Darby bovine kidney (MDBK) and human osteosarcoma U2OS cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin in 5% CO 2 at 37°C. Wild type (wt) BoHV-1 strain Jura, wt BoHV-5 strain N569
and recombinant viruses were propagated in MDBK cells.
Red recombination for frameshift insertion
The parent BAC, originally designated f115.003 (Wild et al., 2005) , and here renamed f115(DF), contains the complete genome of BoHV-1 strain Jura in the prototype orientation characterized by HindIII D and F fragments (Schwyzer and Ackermann, 1996) . In this BAC, the pBeloBAC11 sequence required for propagation in bacteria, adjacent to the eGFP gene under control of the hCMV IE promoter, has been inserted with flanking loxP sites between the BoHV-1 circ and BICP27 loci (Tobler et al., 2002) . The protocol for Red recombination in E. coli strain SW102 was applied according to published procedures (de Oliveira et al., 2008; Warming et al., 2005) . Briefly, in a first step, a DNA fragment containing the galK expression cassette flanked by 50-bp homology arms targeting the BoHV-5 specific frameshift (Fig. 1A) was electroporated into SW102 bacteria harboring the f115(DF) BAC, and recombinant BAC clones were selected on galactose minimal medium plates. The resulting f115-2-galK BAC, in which the BICP0 gene is disrupted, was targeted in a second step by double stranded oligonucleotides to restore BICP0 and to generate a mutant BAC containing the BoHV-5 specific frameshift (f115-B5) and a revertant BAC (f115-K1).
Step 1. The galK cassette with suitable homologous ends for the frameshift insertion was generated by PCR on the pgalK plasmid using 1 pmol each of primer fs57 and primer fs58 ( Table 1 ). The reaction was performed using Phusion polymerase (F-530-S, Finnzymes) with an initial denaturation step at 98°C for 60 sec followed by 35 cycles of 98°C for 30 sec, annealing at 60°C for 30 sec and elongation for 45 sec at 72°C. The resulting fragment was purified after 1% agarose gel by QiaexII extraction as recommended by the manufacturer (Qiagen) and used for electroporation.
Correct insertion of the galK cassette in the f115-2-galK BAC was checked by AsuII cleavage and by PCR (Fig. 2) , using primer pairs fs_seq_7 and fs38; fs33 and fs34; fs37 and o2 (Table 1) . These reactions were performed using TaqBeads (Amersham) in 25 µl containing 1 pmol of the appropriate primer pair, 0.1 µg of template DNA and 1 M betain, with denaturation at 95°C for 3 min, followed by 35 cycles at 95°C for 1 min, 56°C for 30 sec, and 72°C for 1 min.
The fragments were analyzed on a 2% agarose gel.
Step 2. The cassette in the f115-2-galK BAC was exchanged by electroporation of the annealed oligos fs59 and fs60 (Table 1) into electrocompetent and recombinase-induced SW102 cells using counterselection on DOG plates to create the frameshift mutant f115-B5 BAC. To create the revertant f115-K1 BAC, the galK cassette in f115-2-galK was replaced by the annealed oligos fs61 and fs62 in a similar fashion.
Red recombination for replacement of the BICP0-1 ORF
The galK cassette targeting the entire BICP0-1 ORF was generated by PCR on the pgalK plasmid using 1 pmol each of primer fs55 and primer fs56 ( Table 1 ).
The reaction was performed using Phusion polymerase, and the isolated fragment was used to generate the f115-d0-galK BAC, which was characterized as above.
Construction of transfer plasmids
Cloning of the BICP0-5 ORF in pBSKS+ has been described (Zumsteg, 2006) .
The resulting plasmid pBSKS+BICP0-5 contains the entire BICP0-5 ORF flanked by PCR-generated restriction sites, a KpnI site upstream and a BamHI site downstream. The BamHI site replaces the stop codon because pBSKS+BICP0-5 was designed for constructing fusion proteins . The BoHV-1 homology arms extending 960 bp upstream and 970 bp downstream from the BICP0-1 ORF boundary were joined to pBSKS+BICP0-5 as follows. (1) The downstream arm was generated from a BoHV-1 template by PCR using primers fs69 and fs70 (Table 1 ). The product was cleaved with BamHI and SpeI and inserted into pBSKS+BICP0-5 to give pBICP0-5-down.
(2) pBHPJ6 containing BoHV-1 sequence 99'700-106'500 (Wirth et al., 1991) was cut with AvrII and Asp718I, then after filling overhanging ends with T4 DNA polymerase religated to give pBHAKJ4 containing the upstream arm. To add the HA tag, oligonucleotides HATag1 and HATag2 (Table 1) were annealed, cleaved with BamHI and inserted into the BamHI site of pBICP0-5-transf, producing pBICP0-5-HA in two orientations. The correct orientation was identified by cleavage with AflII and nearby restriction sites.
Transfection of mammalian cells and virus rescue
In a 24-well plate, each well was seeded with 10 5 U2OS or MDBK cells and one day later transfected with 1 µg of f115-B5 or f115-K1 BAC DNA using Lipofectamine2000 (Invitrogen). To remove the bacterial sequences of the BAC, 0.05 µg of a Cre recombinase expressing plasmid (p116) was cotransfected (de Oliveira et al., 2008) . One day after transfection of the BAC DNA, cells were examined in a Zeiss Axiovert S 100 fluorescence microscope. Virus was harvested 1-3 days after transfection. To rescue virus by homologous recombination with transfer plasmids encoding BICP0-5 (Fig. 1B) , six-well plates were seeded with 5x10 5 MDBK cells and one day later cotransfected with f115-d0-galK BAC (1-2 µg) and pBICP0-5-transf or pBICP0-5-HA (both in the range of 0.2 to 2 µg) using Lipofectamine2000 as above.
Circular virus DNA for electroporation into bacteria and BAC regeneration.
In 6-cm plates, MDBK cells were infected with rf115-BICP0-5 or rf115-BICP0-5-HA (m.o.i. = 5). After 4 h, cells were washed twice with PBS, then scraped with 0.7ml of 10mM EDTA, 10mM Tris-HCl, pH 8.0 into a tube. After addition of SDS to 0.6% and proteinase K to 0.25g/l, the resulting extract (Gabev et al., 2009) was kept on ice (<1 h); aliquots (1-3 µl) were used for electroporation of E. coli strain DH10 as above, and colonies were isolated on chloramphenicol plates.
Results
Introduction of a BoHV-5-specific frameshift mutation into the BoHV-1 BAC using Red recombination
Comparison of the complete genome sequences of BoHV-1 and BoHV-5 shows that the immediate-early gene for BICP0 is among the least conserved genes (70% amino acid identity vs. 82% overall) and may contribute to a dissimilar phenotype. The most salient difference between BICP0-1 and BICP0-5 is in the C-terminal region due to a cluster of six guanosines in the BICP0-1 gene which aligns with only five guanosines in the BICP0-5 gene. This frameshift leads to an alternative stop codon further downstream and results in a completely different C-terminal amino acid sequence (residues 643-676 of BICP0-1 vs.
655-720 of BICP0-5).
To investigate the effect of the BoHV-5 specific frameshift mutation in the context of the BoHV-1 genome, we used the Red recombination strategy with galK selection and counterselection (de Oliveira et al., 2008) . In the first step, the PCR-amplified galK cassette was inserted by homologous Red recombination into the parent f115(DF) BAC in place of a single guanosine at position 1924 in the BICP0-1 ORF (Fig. 1A) . Positive selection on galactose minimal medium plates yielded the f115-2-galK BAC, in which the BICP0 gene is disrupted.
Successful integration of the galK cassette was confirmed by PCR (Fig. 2) . In the second step, the galK cassette was replaced with the desired target sequence using counterselection on 2-deoxy-galactose (DOG) plates. The resulting mutant and the corresponding revertant, generated accordingly, were named f115-B5
BAC and f115-K1 BAC, respectively. Both recombinants were marked with a translationally silent point mutation to provide a diagnostic restriction enzyme cleavage site (AvrII for f115-B5 and KpnI for f115-K1). Fig. 3 shows KpnI/SpeI restriction enzyme fragments of BAC DNA from eleven clones separated by field inversion gel electrophoresis (FIGE), eight of which exhibited the expected bands for f115-K1, notably the 14'422-bp and 4'969-bp bands resulting from the diagnostic KpnI site in the 19'391-bp fragment of the parent BAC. The remaining clones were unexpected: one probably corresponded to input f115-2-galK (Fig. 3, lane 11) , one to parent f115(DF) (Fig. 3, lane 6) , and one presented an unexplained hypermolar band of about 12'800 bp (Fig. 3, lane 9 ). In the same way, clones of f115-B5 BAC were identified using restriction enzymes AvrII and AflII for analysis (not shown).
To rescue recombinant viruses, BAC DNA was transfected into MDBK cells as well as into human U2OS cells. The latter were included in this experiment with regard to our earlier report that BICP0-1 interacts with p53, a protein which is produced at high levels in U2OS cells. Virus plaques appeared 24 hours later (Fig. 4) , shown as wide field images (top) and fluorescence microscopy images of the same field (bottom). Fluorescence due to eGFP encoded by the recombinants (Fig. 4 , panels a to c) was no longer detectable after cotransfection of f115-B5 BAC DNA with the Cre recombinase expressing plasmid p116 in an equimolar ratio (Fig. 4d) . Recombinant BoHV-1 was isolated from transfected MDBK cells, plaque purified, and designated rf115-K1, rf115-B5 (both containing the F plasmid), and r115-B5 (lacking the F plasmid).
Growth of recombinant and revertant BoHV-1 in MDBK cells was examined at low and high multiplicity of infection (0.01 and 5 m.o.i.). Compared with wild
type BoHV-1 (Jura), rf115-B5 and r115-B5 replicated with equal efficiency, as did the revertant rf115-K1, all reaching titers of 10 8 TCID 50 /ml with similar kinetics (data not shown). Thus, neither the BoHV-5 specific C-terminal region of BICP0 nor the presence of the F plasmid did influence the course of lytic infection.
Classical recombination of the BoHV-1 BAC in MDBK cells to replace the entire BICP0-1 gene by the BICP0-5 gene
Attempts to replace the entire BICP0-1 gene by the BoHV-5 homolog in the BICP0-negative BoHV-1 BAC f115-d0-galK, which was obtained without difficulties by Red recombination, failed repeatedly. Taking into account that, although BICP0 is not strictly essential for lytic infection of BoHV-1, BICP0
null mutants grow to at least 100-fold reduced titers because they lack the transactivation function of that IE protein (Geiser et al., 2005; Köppel et al., 1996) Southern blotting using a BICP0-5 probe (Fig. 5A , lanes 1 to 6). All patterns corresponded to the prediction from the sequence. To show that BACs can be regenerated from rf115-BICP0-5, circular virus DNA was extracted (Gabev et al., 2009 ), electroporated into E. coli DH10, and the resulting BAC DNA was analyzed. Cleavage with BamH1 (Fig. 5A ) revealed the two isomers: the prototype orientation (lane 10), and the U S -inversion (lane 9).
Since available antisera directed against BICP0-1 (Fraefel et al., 1994) were barely able to detect BICP0-5 in Western blots or by indirect immunofluorescence, a further transfer plasmid designated pBICP0-5-HA was constructed which contains the codons for a synthetic influenza hemagglutinin (HA) tag and a silent diagnostic AflII site fused in frame to the 3'-end of the BICP0-5 coding sequence. Upon cotransfection as described above, the viruses named rf115-BICP0-5-HA and r115-BICP0-5-HA were isolated whose genomic DNAs displayed the predicted restriction enzyme cleavage patterns, including the altered AflII pattern resulting from the diagnostic site (Fig. 5A, lanes 7, 8) . In
Western blots, the HA-tagged BICP0-5 migrated with an apparent Mr of about 105 kDa (Fig. 5B ) which is slightly larger than the 97 kDa observed for wt BICP0-1 (Fraefel et al., 1994) and seems consistent with the difference in length (731 vs. 676 amino acids).
Growth kinetics of recombinant BoHV-1
Growth characteristics in MDBK cells of r115-BICP0-5, r115-BICP0-5-HA, wt
BoHV-1 strain Jura, and wt BoHV-5 strain N569 were compared after infection of cells at an m.o.i. of 0.01 and 5 (Fig. 6 ). Titers of virus released into cell culture supernatants and titers of virus remaining associated with cell pellets were determined separately. At low m.o.i., all four viruses reached similar titers of about 10 8.5 TCID 50 /ml in the supernatant (Fig. 6A ) and 10 7 TCID 50 /ml in the pellet (Fig. 6B) . The kinetics were not significantly different, except for the comparison between wt BoHV-1 and r115-BICP0-5, where the latter produced considerably higher titers (>1 log) at 24 h and 48 h, suggesting a slight growth advantage. At high m.o.i., r115-BICP0-5 was released into the supernatant clearly faster than the other three viruses (Fig. 6C) , whereas all other comparisons revealed no significant differences ( Fig. 6C and 6D ).
Taken together, these results demonstrate unequivocally that BICP0 encoded by BoHV-5 can fully functionally complement the replication defect caused by deletion of the homologous gene from the BoHV-1 genome.
Discussion
The Red recombination strategy with galK selection and counterselection permits efficient introduction of mutations into BACs (Warming et al., 2005) and has also been used before in our laboratory (de Oliveira et al., 2008) . During the work described here, we experienced unexpected difficulties with this strategy when the entire BICP0-5 gene was used for insertion into the f115-d0-galK BAC. Among the resulting BACs we observed a great variety of restriction enzyme patterns. Most of them were not as expected, a few initially correct but genetically unstable. In the BICP0 locus, galK appears to be prone to elimination by undesired recombination events. Recently, analysis of many intertypic recombinants between two strains of BoHV-1 has demonstrated that the recombination frequency is unequally distributed over the BoHV-1 genome, and highest in the U S region as well as between U S and the BICP0 locus (Muylkens et al., 2009) . Similarly, intertypic recombination between BoHV-1 and BoHV-5 was shown to be favored by stretches of very high GC content (>90%) and to occur between very short (38 and 44 bp) segments of perfect sequence homology (Del Medico Zajac et al., 2009b) . We assume that the BICP0 locus is a hotspot of legitimate or illegitimate recombination also in bacteria which, however, needs to be verified.
We therefore exploited the transactivation function of BICP0, a major IE protein of BoHV-1 and BoHV-5 which is not essential but beneficial for BoHV replication in cell culture. The alternative strategy presented here ( elsewhere (Steiner et al., 2009) (Vogt, B., Schraner, E., Steiner, F., Ackermann, M., Wild. P., and Schwyzer, M., unpublished) . All these viruses contain the BoHV-1 backbone, in which BICP0-1 is the only gene replaced by BICP0-5 or its derivatives. In vitro, all recombinants replicate at least as efficiently as wt
BoHV-1 or even approach the more efficient wt BoHV-5 (Fig. 6 ), enabling now in vivo studies of neuropathogenesis and latency.
In summary, our results show that BICP0-5 can be tagged at the carboxyterminus of the protein and that wt and HA-tagged BICP0-5 can fully complement the BICP0-1 function for BoHV-1 growth in vitro. We further demonstrate that BICP0-5 can be used to improve isolation of BoHV-1 recombinants generated in a BICP0-negative genomic background, an approach that uses a regulatory active protein which, to the best of our knowledge, has not been described for alphaherpesviruses before.
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